-
1
-
2
-
3
-
4
-
5
-
6
-
7
-
8
-
9
-
10
-
11
-
12
-
13
-
14
-
15
-
16
Unique platinum–DNA interactions may lead to more effective platinum-based antitumor drugs
Veröffentlicht in Metallomics
VolltextArtikel -
17
-
18
1504MO Phase II trial of Pembrolizumab and OLApaRib (POLAR) maintenance for select patients (pts) with metastatic pancreatic cancer (mPC) with (A) homologous recombination deficiency (HRD), (B) non-core HRD (ncHRD) and (C) exceptional response to platinum
Veröffentlicht in Annals of oncology
VolltextArtikel -
19
Platinum Catalysed Hydrosilylation of Propargylic Alcohols
Veröffentlicht in Platinum metals review
VolltextArtikel -
20